COVID-19 and Elevated D-Dimer: A Tale of Caution

J Gen Intern Med. 2022 Apr;37(5):1304-1305. doi: 10.1007/s11606-021-07280-9. Epub 2022 Jan 6.

Authors

Moises Auron¹, Mateo Porres-Aguilar², Scott J Cameron³

Affiliations

¹ Department of Hospital Medicine, Cleveland Clinic, Cleveland, OH, USA. auronm@ccf.org.
² Division of Hospital Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
³ Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Biomarkers
COVID-19*
Fibrin Fibrinogen Degradation Products
Humans
SARS-CoV-2

Substances

Biomarkers
Fibrin Fibrinogen Degradation Products
fibrin fragment D

Grants and funding

L30 HL120200/HL/NHLBI NIH HHS/United States